Targeting neutrophil serine proteases in bronchiectasis
European Respiratory Journal · 2025-01 · 65 (1) · 2401050
DOI: 10.1183/13993003.01050-2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Respiratory Journal, online erschienen am 28.10.2024. Verfasst von James D Chalmers und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: Bronchiectasis, Neutrophils, Cathepsin C, Serine Proteases. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Boehringer Ingelheim.
Abstract (Originalsprache)
Persistent neutrophilic inflammation is a central feature in both the pathogenesis and progression of bronchiectasis. Neutrophils release neutrophil serine proteases (NSPs), such as neutrophil elastase (NE), cathepsin G and proteinase 3. When chronically high levels of free NSP activity exceed those of protective antiproteases, structural lung destruction, mucosal-related defects, further susceptibility to infection and worsening of clinical outcomes can occur. Despite the defined role of prolonged, high levels of NSPs in bronchiectasis, no drug that controls neutrophilic inflammation is licensed for the treatment of bronchiectasis. Previous methods of suppressing neutrophilic inflammation (such as direct inhibition of NE) have not been successful; however, an emerging therapy designed to address neutrophil-mediated pathology, inhibition of the cysteine protease cathepsin C (CatC, also known as dipeptidyl peptidase 1), is a promising approach to ameliorate neutrophilic inflammation, since this may reduce the activity of all NSPs implicated in bronchiectasis pathogenesis, and not just NE. Current data suggest that CatC inhibition may effectively restore the protease–antiprotease balance in bronchiectasis and improve disease outcomes as a result. Clinical trials for CatC inhibitors in bronchiectasis have reported positive phase III results. In this narrative review, we discuss the role of high NSP activity in bronchiectasis, and how this feature drives the associated morbidity and mortality seen in bronchiectasis. This review discusses therapeutic approaches aimed at treating neutrophilic inflammation in the bronchiectasis lung, summarising clinical trial outcomes and highlighting the need for more treatment strategies that effectively address chronic neutrophilic inflammation in bronchiectasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, UK.
- J.D. Chalmers and M.A. Mall are joint first authors.
- Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany…
- German Center for Child and Adolescent Health (DZKJ), partner site Berlin, Berlin, Germany.
- German Center for Lung Research (DZL), associated partner site Berlin, Berlin, Germany.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
ORCID-Profile: Marcus A Mall, Sanjay H Chotirmall, Felix C Ringshausen, Jin-Fu Xu, Michal Shteinberg
Förderung
- Boehringer Ingelheim
Zitieren
APA
Chalmers, J. D., Mall, M. A., Chotirmall, S. H., O'Donnell, A. E., Flume, P. A., Hasegawa, N., Ringshausen, F. C., Watz, H., Xu, J. F., Shteinberg, M., & McShane, P. J. (2025). Targeting neutrophil serine proteases in bronchiectasis. European Respiratory Journal, 65(1), 2401050. https://doi.org/10.1183/13993003.01050-2024
Vancouver
Chalmers JD, Mall MA, Chotirmall SH, O'Donnell AE, Flume PA, Hasegawa N, et al. Targeting neutrophil serine proteases in bronchiectasis. European Respiratory Journal. 2025;65(1):2401050. doi:10.1183/13993003.01050-2024
BibTeX
@article{Chalmers2025,
author = {Chalmers, James D and Mall, Marcus A and Chotirmall, Sanjay H and O'Donnell, Anne E and Flume, Patrick A and Hasegawa, Naoki and Ringshausen, Felix C and Watz, Henrik and Xu, Jin-Fu and Shteinberg, Michal and McShane, Pamela J},
title = {Targeting neutrophil serine proteases in bronchiectasis},
journal = {European Respiratory Journal},
year = {2025},
volume = {65},
number = {1},
pages = {2401050},
doi = {10.1183/13993003.01050-2024}
}
EUVIMED